clinical trial · NCT05089357
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
Galderma R&D·—·completed·n = 250
Glabellar LinesAbobotulinumtoxinA
brief summary
This is a prospective, longitudinal, non-interventional, multi-center study to collect subject and physician satisfaction, and treatment experience with Dysport in real clinical practice in subjects of Chinese origin.
started
Nov 11, 2021
primary completion
Sep 12, 2023
completion
Dec 24, 2023
last updated
Jul 9, 2025
detailed description
Approximately 250 subjects are planned to be included in the study.
official title
A Prospective, Non-interventional Study to Collect Subject and Physician Satisfaction During Long Term Treatment of Glabellar Lines With Dysport® in Subjects of Chinese Origin in Real Clinical Practice
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol